Energy-cycle metabolite · Fact sheet

Alpha-ketoglutarate

Also known as AKG · 2-oxoglutarate · calcium alpha-ketoglutarate · Ca-AKG

Alpha-ketoglutarate is not an FDA-approved anti-aging drug. Animal studies and a human trial program make it a legitimate geroscience candidate, but there is no evidence that AKG extends human life or prevents age-related disease.

In clinical trialsMostly animal or lab research

What is Alpha-ketoglutarate?

AKG is a normal intermediate in the citric-acid cycle and a cofactor for enzymes involved in amino-acid metabolism and gene regulation.

Supplement research often uses a calcium salt, which should not be treated as identical to endogenous AKG biology or every commercial formulation.

Benefits & claims

A mouse study reported improved healthspan measures and compressed morbidity, with smaller lifespan effects than many headlines implied.

The ABLE randomized trial was designed around DNA-methylation age and functional measures, but a protocol is not an outcome.

What the evidence supports

  • Mouse work reported lower frailty and compressed late-life morbidity under selected conditions.
  • Human randomized research can test biomarker and functional hypotheses, but no result yet establishes better healthspan.
Research areas
  • Healthspan and frailty in animals
  • DNA-methylation age
  • Inflammatory and metabolic biomarkers
  • Muscle and vascular function

Dosage & frequency

No established human regimen

Human AKG trials study particular salts and formulations. There is no FDA-approved AKG longevity dose, and changes in aging biomarkers do not establish longer life.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Calcium AKG, other AKG salts, and combination products are not interchangeable evidence.

Interactions & precautions

  • The reviewed AKG trial sources do not establish an interaction profile shared by calcium AKG, other salts, and combination supplements.

What is still unresolved

  • Which formulation and amount, if any, improves meaningful aging outcomes?

Side effects & risks

  • Long-term safety of concentrated supplementation in diverse populations is not well characterized.
  • Different salts and formulations may have different composition and absorption.
  • Changes in a biological-age clock may not represent a meaningful change in health.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Mostly animal or lab research

Healthspan evidence is dominated by animal and mechanistic work. Human studies have focused on feasibility, observational biomarkers, or trial design rather than demonstrated clinical benefit.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 3 sourced accounts by reported effect.

Sleep: reported experiences

Negative account · personal report

Loose stools and poorer sleep

A separate commenter reported loose stools and worse sleep with an AKG supplement and questioned whether product quality contributed.

Reported use in this account

Product
AKG supplement; formulation not stated
Amount
1,000 mg
Frequency
Daily
Route
Not specified clearly
Duration
Not specified clearly

The formulation, product quality and other causes were not verified. The report cannot be transferred to every AKG salt.

Read the digestive-and-sleep account

Approval status

AKG has been studied in a randomized human geroscience program but has no FDA-approved use for aging, biological-age reduction, frailty, or disease prevention.

Human geroscience trial program

Alpha-ketoglutarate has a Phase 2 biological-age trial record and a published protocol, but no FDA-approved anti-aging, frailty, or disease-prevention use.

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Whether AKG changes validated human aging outcomes
  • Whether epigenetic-clock changes are reproducible and clinically meaningful
  • Long-term safety and interactions
  • Which formulation and population, if any, has a favorable benefit-risk profile

Summary

AKG has animal aging research, but human healthspan benefits remain unproven.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. pubmedAKG mouse healthspan and lifespan study

    Preclinical study that cannot establish human longevity or disease-prevention benefit.

  2. pubmedABLE randomized human study protocol

    Prospective design for biomarker and functional research, not a favorable result.

  3. clinical trialsClinicalTrials.gov: ABLE study

    Official status and endpoint record for the randomized calcium-AKG study.

  4. fdaFDA: dietary supplements are not preapproved for effectiveness

    FDA explanation of the regulatory distinction between approved drugs and marketed dietary supplements.

How we assess sources · Suggest a correction